SHANGHAI MICROPORT ENDOVASCULAR MEDTEC(GROUP)SHANGHAI MICROPORT ENDOVASCULAR MEDTEC(GROUP)SHANGHAI MICROPORT ENDOVASCULAR MEDTEC(GROUP)

SHANGHAI MICROPORT ENDOVASCULAR MEDTEC(GROUP)

No trades
See on Supercharts

688016 fundamentals

SHANGHAI MICROPORT ENDOVASCULAR MEDTEC(GROUP) financial statements, including revenue, expenses, profit, and loss

The total revenue of 688016 for the last quarter is 354.42 M CNY, and it's 19.82% higher compared to the previous quarter. The net income of Q1 24 is 184.30 M CNY.

Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: CNY
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth